Quantcast

Latest PDE5 inhibitors Stories

2010-12-05 00:13:33

New clients are invited to use the services of a web pharmacy that has been created recently to provide customers with the most popular drugs, like generic Cialis, for the most competitive prices. Las Vegas, NV (PRWEB) December 3, 2010 It is natural that all customers using the services of online pharmacies would like to get high quality medicines, paying less for them and getting their order within the shortest possible time. That is why emergence of rxbuys.com is very timely and...

2010-11-08 05:30:00

MOUNTAIN VIEW, Calif., Nov. 8, 2010 /PRNewswire-FirstCall/ -- VIVUS, Inc. (Nasdaq: VVUS) today announced that it has closed the sale of its MUSE business to Meda. Under the purchase agreement, Meda acquired the MUSE assets including the United States and foreign MUSE patents, existing inventory and the manufacturing facility located in Lakewood, New Jersey. As part of the transaction, most of the former VIVUS employees that were MUSE dedicated, including the field sales force, have joined...

caecd83adbf8301078b289e9f3f4cc201
2010-10-19 09:25:00

Viagra, the famous little blue pill that millions of men use for erectile dysfunction, and originally developed to help ailing hearts, may now also help treat heart symptoms of muscular dystrophy, according to researchers Monday. Mice that were genetically engineered to have a condition similar to Duchenne muscular dystrophy were tested and scientists found the drug could improve how the heart works, according to their research. Joseph Beavoa of the University of Washington and colleagues...

2010-10-04 08:55:00

MOUNTAIN VIEW, Calif., Oct. 4 /PRNewswire-FirstCall/ -- VIVUS, Inc. (Nasdaq: VVUS) today announced that it has entered into an asset purchase agreement with Meda - an international specialty pharma company - for MUSE®, transurethral alprostadil, for the treatment of erectile dysfunction (ED). Under the agreement, Meda will acquire the MUSE assets including the United States and foreign MUSE patents, existing inventory and the manufacturing facility located in Lakewood,...

2010-10-01 13:59:27

Feature: Merging of marketing and medical science: female sexual dysfunction Drug companies have not only sponsored the science of a new condition known as female sexual dysfunction, they have helped to construct it, in order to build global markets for new drugs, reveals an article in this week's BMJ. Researching his new book 'Sex, Lies and Pharmaceuticals' Ray Moynihan, journalist and lecturer at the University of Newcastle in Australia, discovered that drug industry employees have worked...

2010-08-17 06:30:00

CRANBURY, N.J., Aug. 17 /PRNewswire-FirstCall/ -- Palatin Technologies, Inc. (NYSE Amex: PTN) today announced positive results of a Phase 1 clinical trial of subcutaneously administered bremelanotide, its melanocortin agonist drug candidate for treatment of male erectile dysfunction (ED) and female sexual dysfunction (FSD). The results demonstrate that with subcutaneous administration consistent therapeutic blood plasma levels can be obtained without sustained clinically significant blood...

14efbeccd66a261bb314232f41a3d93b1
2010-08-06 12:00:13

The Milwaukee Teachers' Education Association (MTEA) union is asking a judge to force the region's school board to reinstate Viagra and other erectile dysfunction drugs to their taxpayer-funded health care coverage, according to a Friday report by Associated Press (AP) writer Ryan J. Foley. According to Foley, "The filing is the latest in a two-year legal campaign in which the union has argued, so far unsuccessfully, that the board's policy of excluding erectile dysfunction drugs...

2010-08-05 07:00:00

MOUNTAIN VIEW, Calif., Aug. 5 /PRNewswire-FirstCall/ -- VIVUS, Inc. (Nasdaq: VVUS) today announced that Timothy Morris, chief financial officer, will present an overview of the company at the Bank of America Merrill Lynch 2010 Specialty Pharmaceuticals Conference. The VIVUS presentation will take place at the Southampton Inn in Southampton, New York on Friday, August 13, 2010 at 10:40 a.m. ET. A live webcast and 30-day archive of the presentation will be available at...

2010-06-24 06:30:00

CRANBURY, N.J., June 24 /PRNewswire-FirstCall/ -- Palatin Technologies, Inc. (NYSE Amex: PTN) today announced the completion of patient dosing and database lock in a double-blind, placebo-controlled, multiple dose, crossover study of bremelanotide, its subcutaneously administered melanocortin agonist for treatment of erectile dysfunction (ED). Palatin expects to report top-line data in the next calendar quarter. The endpoints in the study are evaluation of plasma exposure and blood...

fb905fc98aa63cd7e7d7349aa679b00b1
2010-06-17 06:35:00

The drug industry's latest attempt to find a female equivalent to Viagra fell short in two separate studies, according to federal regulators on Wednesday. The Food and Drug Administration is considering Boehringer Ingelheim's drug flibanserin for pre-menopausal women who experienced a lack in sexual desire, a market that drug makers have been targeting for years since the epic success of Viagra for men. The hunt for a female version of Viagra has proved elusive though, with many drugs...


Word of the Day
humgruffin
  • A terrible or repulsive person.
Regarding the etymology of 'humgruffin,' the OED says (rather unhelpfully) that it's a 'made-up word.' We might guess that 'hum' comes from 'humbug' or possibly 'hum' meaning 'a disagreeable smell,' while 'gruffin' could be a combination of 'gruff' and 'griffin.'